Gastrointestinal Cancer News

Despite a recommendation from the United States Preventive Services Task Force in 2013 for one-time hepatitis C testing among baby boomers, only 13.8% reported testing in 2015, according to a survey conducted by the American Cancer Society.

Bruce E. Johnson, MD, FASCO, professor of medicine at Harvard Medical School and institute physician at Dana-Farber Cancer Institute, will become president of ASCO during the society’s annual meeting in June.

Anal cancer accounts for less than 3% of gastrointestinal malignancies and 0.5% of all new cancer diagnoses in the United States.

Click here to read the Cover Story, “‘Surging burden’ of anal cancer requires more investigation, education’.”

A novel hybrid optical and optoacoustic endoscope under development by researchers at the Institute of Biological and Medical Imaging at Helmholtz Zentrum München could enable early diagnosis and staging of esophageal cancer, which would improve treatment outcomes and lead to “immense cost-savings,” according to a press release.

BTG received Class III CE Mark certification for its DC Bead LUMI, a radiopaque drug-eluting bead for patients with hepatocellular carcinoma and malignant colorectal cancer metastasized to the liver, according to a press release.

Nearly one in 10 patients with colorectal cancer harbored mutations in genes that may increase susceptibility to cancer, according to a study published in Journal of Clinical Oncology.

Individuals who consumed foods rich in dietary fiber and whole grains showed a decreased risk for F. nucleatum–positive colorectal cancer, but not a lower risk for F. nucleatum–negative cancer, a prospective cohort study found.

Investigators associated cigarette smoking with an increased risk for synchronous colorectal cancers in a prospective study.

Researchers at Memorial Sloan Kettering Cancer Center have initiated several studies to assess photodynamic therapy for patients with prostate, esophageal, breast and bladder cancers.